NCT04193462

Brief Summary

A short term dyadic psychotherapy intervention for mothers with Post-Partum depression and their babies in the first year of life was developed. The investigators believe that following dyadic intervention mothers will show improvement in depressive symptoms, the quality of the mother-child relationship will improve, and maternal and infant's oxytocin levels will rise.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 8, 2019

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 1, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 10, 2019

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

May 29, 2024

Status Verified

May 1, 2024

Enrollment Period

5.4 years

First QC Date

November 1, 2019

Last Update Submit

May 27, 2024

Conditions

Keywords

Post-partum depressiondyadic psychotherapyoxytocin

Outcome Measures

Primary Outcomes (2)

  • Behavioral Assessment of dialogue

    Interactions will be coded with the "Coding Interactive Behavior" (CIB) manual (Feldman, 1998), infant version. This version is composed of 37 codes rated on a scale of 1 to 5, as higher score means a better outcome.

    trail 1-baseline

  • Hormonal Assays- Oxytocin

    Three saliva samples will be collected using Salivettes® at baseline, following interaction, and 20 minutes after end and averaged. All samples will be then stored at -20°C. Salivette will be treated as following: centrifuged twice, at 4°C at 1500 x g for 30 minutes, aliquoted and lyophilized over few days- to concentrate by 4 times. The dry samples will be reconstructed in the assay buffer immediately before analysis using an oxytocin enzyme immunoassay commercial kit (ENZO, NY). The assay preformed according the kit's instruction. The concentration of oxytocin will be calculated using MatLab-7

    trail 1-baseline

Secondary Outcomes (2)

  • Behavioral Assessment of dialogue

    trail 2- after treatment- 2-3 months after trail 1

  • Hormonal Assays- Oxytocin

    trail 2- after treatment- 2-3 months after trail 1

Study Arms (3)

Post-partum depression- Dyadic psychotherapy

EXPERIMENTAL

Mothers and infants will be treated with 8 weeks dyadic psychotherapy at their home using video-feedback of mother-infant interaction to discuss main issues in the mother-infant relationship.

Other: Post-partum depression- Dyadic psychotherapy-

Post-partum depression- Psycho-educational therapy

ACTIVE COMPARATOR

8 weeks of supportive therapy for the mother at her house, involving the baby. Each session will include different aspects of psycho-education regarding development of the baby.

Other: Post-partum depression- Psycho-educational therapy

Control- Healthy mothers and their babies

NO INTERVENTION

No intervention for 8 weeks.

Interventions

Mothers and infants will be treated with dyadic psychotherapy focused on interactions, emphasizing eye contact, body language, empathy, and social reciprocity. Dyadic psychotherapy will be administered one time a week during the 8-week trial period, at the subject's home. Each session, approximately 90 minutes long, will include videotaping mother-infant interaction, watching the last session's interaction as a part of video-feedback technique, and discussing main issues in the mother-infant relationship. In addition, each session will begin and end with a- 5-minute episode of affectionate touch and gaze synchrony between the mother and her infant. During the whole therapy-trial, the therapist will also use cognitive-behavioral approach to address the mother's perception of her infant and of herself as a mother.

Post-partum depression- Dyadic psychotherapy

Mothers will receive a therapy in their homes for 8 weeks, 1.5 hours for each session by a therapist arriving at their home. Each session will address a different developmental aspects of the baby (feeding, movement, social-emotional development etc.). Therapist will ask the mother about her baby, will give information about developmental needs and expectations and will help mother to enrich child's development and deal will potential problems

Post-partum depression- Psycho-educational therapy

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • women diagnosed with Post-Partum depression, major or minor, according to the Diagnostic and Statistical Manual of Mental Disorders, 5th version (DSM-5)
  • months after birth of one baby

You may not qualify if:

  • Mothers of twins
  • Mothers of premature babies
  • Comorbidity of psychopathology, women who have severe personality disorder or other psychiatric diagnose, besides depression or anxiety
  • Women or babies who suffer from severe medical condition, such as developmental problems for the baby or disability.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Interdisciplinary Center

Herzliya, 4610101, Israel

RECRUITING

MeSH Terms

Conditions

Depression, Postpartum

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental Disorders

Study Officials

  • Moran Influs, Phd

    Interdisciplinary Center Herzliya, Israel

    STUDY DIRECTOR

Central Study Contacts

Moran Influs, Phd

CONTACT

Ruth Feldman, Phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 1, 2019

First Posted

December 10, 2019

Study Start

May 8, 2019

Primary Completion

October 1, 2024

Study Completion

December 1, 2024

Last Updated

May 29, 2024

Record last verified: 2024-05

Locations